For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 99,127 | |||
| General and administrative | 22,987 | |||
| Total operating expenses | 122,114 | |||
| Loss from operations | -122,114 | |||
| Interest income | 5,777 | |||
| Interest expense | 36 | |||
| Other expense, net | -430 | |||
| Loss before income tax provision | -116,803 | |||
| Income tax provision | 0 | |||
| Net loss | -116,803 | |||
| Unrealized gain on treasury securities, net of tax | 86 | |||
| Total other comprehensive income | 86 | |||
| Comprehensive loss | -116,717 | |||
| Basic EPS | -16.95 | |||
| Diluted EPS | -16.95 | |||
| Basic Average Shares | 6,891,336 | |||
| Diluted Average Shares | 6,891,336 | |||
Adicet Bio, Inc. (ACET)
Adicet Bio, Inc. (ACET)